BioSpace News Archive

Career Advice

How to Get Your Confidence Back After a Layoff

If you’re having trouble finding your confidence again, try these tips for regaining a (healthy) ego.

December 17, 2019
·
2 min read
·
Laura Brothers
Biotech Bay

Aging in Waves: New Findings on Aging-Related Proteins in the Blood

In an effort to understand aging, researchers from Stanford University and colleagues around the world analyzed almost 3,000 proteins in the blood of more than 4,000 people ages 18 to 94.

December 17, 2019
·
5 min read
·
Mark Terry
Drug Development

GSK Submits Multiple Myeloma Drug to Regulators in Hopes of Competing with J&J’s Darzalex

GlaxoSmithKline announced results from its pivotal DREAMM-2 Phase III trial of belantamab mafodotin in multiple myeloma.

December 17, 2019
·
2 min read
·
Mark Terry
Deals

Velano Secures Additional Funding to Meet Commercial Demand for PIVO, Fueled by Industry Move to One-Stick Hospitalization

Latest funding caps year of groundbreaking milestones for transformative vascular access company; new capital will be used to meet rapidly growing hospital and patient demand

December 17, 2019
·
2 min read
Business

ELRIG UK and British Pharmacological Society collaborate to improve scientific exchange in UK drug discovery

Major learned societies initiate two-year strategic alliance

December 17, 2019
·
3 min read
Policy

Baebies Announces CE Mark for FINDER, an Innovative Near-Patient Testing Platform for Glucose-6-Phosphate Dehydrogenase

Baebies is pleased to announce that FINDERTM, a near-patient testing platform, now has CE Mark as an In Vitro Diagnostic device and is commercially available in Europe and other countries that recognize CE Mark.

December 17, 2019
·
3 min read
FDA

Pfizer and Astellas’ Xtandi Wins FDA Approval for New Prostate Cancer Indication

With the latest approval, Xtandi, an androgen receptor inhibitor, is now the only oral treatment approved by the FDA for three distinct types of advanced prostate cancer – non-metastatic and metastatic castration-resistant prostate cancer (CRPC) and mCSPC.

December 17, 2019
·
2 min read
·
Alex Keown
Drug Development

BeiGene’s Brukinsa Falls Short Against J&J’s Imbruvica in Blood Disease Trial

Almost one month after BeiGene’s Bruton’s kinase inhibitor Brukinsa won accelerated approval for mantle cell lymphoma, the company reported the drug failed to hit the mark in a late-stage trial assessing the drug as a treatment for Waldenström’s macroglobulinemia.

December 17, 2019
·
2 min read
·
Alex Keown
Business

Opinion: What Is Personalized Medicine And Why Is It So Important?

The same shoe size fits everyone with similar feet, but this approach doesn’t work so well for medical treatment.

December 17, 2019
·
5 min read
Business

Novoheart and Harvard Partner on Heart-in-a-Jar Technology to Advance Cardiac Drug Development

The deal allows Novoheart to merge its MyHeart Platform with Harvard’s tissue-engineered scale model of the heart ventricle and bioreactor technology.

December 17, 2019
·
3 min read
·
Mark Terry